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Background: Alzheimer’s disease (AD) is a neurodegenerative disease of the brain and the 
most common form of dementia in the elderly. Aneuploidy, a state in which cells have an 
abnormal number of chromosomes, has been proposed to play a role in neurodegeneration 
in AD patients. Several studies using fluorescence in situ hybridization have shown that the 
brains of AD patients contain an increased number of aneuploid cells. However, because the 
reported rate of aneuploidy in neurons ranges widely, a more sensitive method is needed to 
establish a possible role of aneuploidy in AD pathology.  
Results: In the current study we used a novel single-cell whole genome sequencing (scWGS) 
approach to assess aneuploidy in isolated neurons from the frontal cortex of normal control 
individuals (n=6) and patients with AD (n=10). The sensitivity and specificity of our method 
was shown by the presence of 3 copies of chromosome 21 in all analyzed neuronal nuclei of a 
Down syndrome sample (n=36).  Very low levels of aneuploidy were found in the brains from 
control individuals (n=589), and AD patients (n=893). In contrast to other studies, we observe 
no selective gain of chromosomes 17 or 21 in neurons of AD patients. 
Conclusion: scWGS showed no evidence for common aneuploidy in normal and Alzheimer’s 
disease neurons. Therefore, our results do not support an important role for aneuploidy in 







Aberrant chromosome copy numbers, aneuploidy, has been observed in the developing and 
adult human brain. However, the reported frequency of neuronal aneuploidy varies widely 
(up to 40%, with an average of ~10%) 1–3 with some studies reporting no aneuploid cells at all 
4,5. Since neurons are post-mitotic, the number of methods to screen for aneuploidy is limited 
and most of the previous studies used interphase fluorescence in situ hybridization (FISH). 
Interestingly, several recent studies using single-cell whole genome sequencing (scWGS) 
consistently found low levels (2-5%) of aneuploid neurons in the human brain 6–8. Compared 
to interphase FISH, which is intrinsically noisy 9, scWGS has three important advantages: 1) all 
chromosomes in each single cell can be analyzed (in contrast to a maximum of four 
chromosome-specific probes for interphase FISH), 2) each chromosome is probed thousands 
of times per cell (thousands of unique reads per chromosome representing distinct 
chromosomal regions), and 3) the results are not affected by variable probe hybridization or 
artifacts related to tissue sectioning or other causes which can result in false positive or false 
negative results. These advantages make single cell sequencing at least in theory a more 
robust method for detecting aneuploidy.  
Interestingly, aneuploidy is thought to be involved in the pathogenesis of Alzheimer’s disease 
(AD), the most common form of dementia 10. Several studies have reported an increased level 
of aneuploid cells in the brains of AD patients 1,5,11–15. For example, some studies showed that 
extra copies of chromosomes 11, 17, 18 and 21 were more prevalent in neurons from AD 
patients compared to controls 5,11–13,15. In contrast, other studies reported evidence for 
selective aneuploidy such as a 10-fold increase in chromosome 21 aneuploidy 12 or a 2-fold 
increase in X chromosome aneuploidy 14. That extra copies of chromosome 21 were 
repeatedly described in AD neurons is interesting in view of observations that individuals with 
Down syndrome (DS), who also have an extra copy of chromosome 21, are much more likely 
to develop AD and at an earlier age than euploid individuals 16. Based on such observations it 
was postulated that trisomy of chromosome 21 and the resulting extra copy of the amyloid 
precursor protein (APP) gene, located on chromosome 21, could contribute to the 
pathogenesis of AD. Indeed, mutations in APP are observed in patients with familial AD and 
are known to cause early onset AD 17. In contrast, Thomas and Fenech, although finding high 
levels of aneuploidy in hippocampal cells for chromosome 17 and 21 (18% and 12% for chr. 17 
and 21 respectively), found no difference in aneuploidy rates from brains of AD and controls 
15, questioning the involvement of trisomy 21 and 17 in the pathogenesis of AD.  
Since the reported rates of aneuploidy in AD brains are mostly based on interphase FISH 
studies and vary widely, we used scWGS to re-examined neuronal karyotypes in individuals 
with different stages of dementia to determine the frequency of aneuploidy in normal and AD 
brain. We developed a pre-amplification-free library preparation method and validated its 
ability to karyotype single cells by confirming the presence of three copies of chromosome 21 
in single DS cells. We found very low levels of aneuploid neurons in control and AD brains. 
Also, no aneuploidy was found in non-neuronal cells of a control and AD sample. Collectively, 
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these results show that aneuploidy is not common in normal and AD brain and thus unlikely 
to contribute to the pathogenesis of AD.  
 
Results and discussion 
Validation of the pre-amplification-free method of preparing libraries 
In this study we used single-cell sequencing to assess the presence of aneuploid cells in the 
frontal cortex of normal post mortem brains and brains affected by AD (Braak stage III to VI). 
The presence of amyloid plaques in some of the brain samples classified with Braak stages III 
and VI was confirmed by amyloid β (Aβ) staining (Fig. 1). Nuclei were isolated from sections 
that were directly adjacent to sections with amyloid plaques. Single neuronal nuclei were 
sorted based on the nuclear neuronal marker NeuN as described previously 18. scWGS libraries 
were prepared without whole genome pre-amplification (Fig. S1), reducing PCR amplification 
bias and thereby maintaining a more direct correlation between sequence reads and genome 
content. The distribution of reads across the chromosomes was used as a faithful indicator of 
the chromosome copy number. Since there is no pre-amplification step, a particular genomic 
location is expected to be represented in libraries only twice, one from each homolog of 
diploid individuals. Although the genomic coverage without pre-amplification is low, losses of 
genomic DNA during library preparation were typically found to be random. As a result, the 
distribution of reads mapping uniquely to the reference genome is rather even which allows 





Figure 1. Examples of beta-amyloid plaque staining. Representative images of the area of the frontal 
cortex from where nuclei for sequencing were isolated of control individual (A) or AD patients with 
Braak stage III (B) or VI (C). 
 
The copy number state of each chromosome was determined using an in-house developed 
algorithm called Aneufinder (described by Bakker et al.19). Briefly, this algorithm bins the 
mapped reads and uses a Hidden Markov Model (HMM) to predict the copy number state (i.e. 
monosomic, disomic, trisomic, etc.) for each bin. The most common state of a chromosome 
was assigned as the copy number for that chromosome. This means that when the majority 
of a chromosome is lost or gained it is called monosomic or trisomic respectively. Only libraries 
that passed the stringent quality metrics as determined by Aneufinder were used for further 
analysis: out of the total of 2664 single cell libraries prepared for this study 1632 libraries 
passed quality control (61%). From these, we obtained on average 858,800 reads per library, 
of which 333,000 reads (with MAPQ>10) mapped to a unique location on the genome, and 
library complexity was estimated to be 950,000 (see supplemental table S1 for more details). 
Importantly, the relatively shallow sequencing of the single cell libraries is sufficient to 
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determine chromosomal copy numbers. Higher coverage is possible by sequencing longer 
reads or fewer libraries per lane. 
To ensure that our approach faithfully and reproducibly annotates aneuploid events, we first 
validated our method by sequencing single neuronal nuclei isolated from a fresh frozen 
postmortem brain sample from an individual with DS. Indeed, in all 36 single cell libraries we 





Figure 2. Trisomy of chromosome 21 is detected in DS cells.  (A) Genome wide copy number plot of a 
single DS cell. Arrow denotes gain as identified by AneuFinder. (B) Genome wide copy number profile 
of a population of DS cells (n=36). Each row represents a single cell with chromosomes plotted as 
columns. Cells are clustered based on the similarity of their copy number profile. Copy number states 
are depicted in different colors.  
 
In addition, two copies of chromosome X were called, as expected from this female individual. 
In contrast, all single neurons analyzed in our study isolated from male individuals had only 
one copy of the X-chromosome (Fig. 3A), further validating our single cell-sequencing 
platform. Finally, scWGS data of several leukemic and solid tumor samples generated using 
this platform, revealed similar overall copy number variation (CNV) patterns as obtained by 
array comparative genomic hybridization (CGH) analysis (Bakker et al.19 and Paranita et al., 
personal communication), validating once more our approach to enumerate aneuploidy in 
single cells. 
 
Low level of aneuploidy in normal neurons 
To assess the rate of aneuploidy in normal healthy brains we examined neurons from six 
control individuals without dementia. Of the 589 control neurons analyzed, all but 4 were 
euploid (Fig. 3A and S2A; tables S2 and S3). These 4 aneuploid cells were found in one control 





of chromosome 6, the third gained a copy of both chromosomes 4 and 16 and the fourth 
gained a copy of 13, 16, 21 and 22. Overall, the total prevalence of aneuploidy, cells with loss 
or gain of one or more chromosomes, in the control samples was 0.7% (95% confidence 
interval (CI): 0.2%-1.8%, n=589). The aneuploidy per chromosome, cells with loss or gain of a 
specific chromosome, ranged from 0%-0.34% in (Fig. 3A and S2; tables S2 and S3). The 
aneuploidy rates that we find in normal brain are remarkably lower than reported by most 
other studies which used (interphase) FISH to detect aneuploidy 1–5. For example when 
comparing these results with the per chromosome aneuploidy rates reported by Iourov et al. 
12 and Yurov et al. 14, we found significantly lower aneuploidy rates for all of the chromosomes 
analyzed in these studies (Mann-Whitney-Wilcoxon rank test, p<0.05 for chr. 1, 7, 11, 14, 17, 
18, 21 and X in Iourov et al., and for chr. 1, 7, 11, 16, 17, 18 and X in Yurov et al.) (table S3). 
 
 
Figure 3. scWGS reveals no common aneuploidy in AD neurons. A representative genome wide copy 
number profile of a population of cells from control 6 (male, n=120) (A) and two AD patients AD 2 
(male, n=37) and AD 4 (female, n=72) (B) sample. Each row represents a single cell with chromosomes 
plotted as columns. Cells are clustered based on the similarity of their copy number profile. Copy 
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The FISH based approach can yield noisy results, especially when used on tissue slides (as 
opposed to single cell suspensions) 9. Our results are more in agreement with other recent 
studies that sequenced single neurons 6–8 and reported low rates (2-5%) of aneuploid cells in 
normal brain. Similar to our analysis, these studies all analyzed human frontal cortical cells: 
McConnell et al. found one chromosome loss and two gains in 110 neurons (2.7%) 6, Cai et al. 
reported 4 out of the 91 analyzed neurons to be aneuploid (4.4%) 7 and Knouse et al. found 2 
aneuploidies 89 cells (2.2%) 8. In summary, while our pre-amplification-free single cell 
sequencing method faithfully detects aneuploidies such as trisomy 21 in a DS individual (Fig. 
2) or X-chromosome monosomy in male cells (Fig. 3 and S2), it detects very low levels of 
aneuploidy in human adult neurons, indicating that previous FISH approaches may have 
overestimated aneuploidy levels in the human brain.  
 
Table 1. Brain samples used and aneuploidy levels found per sample 






Control 1 69 M 0 81 0 (0%) 
Control 2 74 M 0 80 0 (0%) 
Control 3 79 F I 108 0 (0%) 
Control 4 82 F 0 72 4 (5.56%) 
Control 5 84 F I 128 0 (0%) 
Control 6 93 M I 120 0 (0%) 
      
AD 1 64 F VI 32 0 (0%) 
AD 2 66 M IV 37 1 (2.70%) 
AD 3 73 F V 63 0 (0%) 
AD 4 74 F V 72 0 (0%) 
AD 5 76 F III 118 0 (0%) 
AD 6 80 F VI 125 0 (0%) 
AD 7 85 F III 115 0 (0%) 
AD 8 85 F VI 107 0 (0%) 
AD 9 91 F III 109 2 (1.83%) 
AD 10 92 F VI 116 2 (1.72%) 
      
Non-neuron control  84 F I 63 0 (0%) 
Non-neuron AD 92 F VI 51 0 (0%) 
 
 
Low level of neuronal aneuploidy in AD 
While several groups have reported an increased level of aneuploidy in brains of AD patients 
compared to normal healthy brains, these observations were also based on FISH studies. 
Importantly, while our and other’s single cell sequencing experiments 6–8 support that 
aneuploidy in healthy brain has been overestimated in FISH studies, no single cell sequencing 
data was available for AD patients’ neurons. Therefore, we examined 893 neurons from 10 
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individuals with AD to investigate a potential role of neuronal aneuploidy in AD. In contrast to 
previous studies, we did not find evidence for increased aneuploidy in brains of AD patients 
(Fig. 3 and S3, tables 1, S2 and S3). In seven patients no aneuploid cells were found, while in 
the other three patients out of 261 cells a total of five aneuploid cells were found. Of the 
neurons from AD2 one cell had an extra copy of chromosome 6, of AD9 two cells lost either 
chromosome 3 or 21, and in AD10 one cell lost chromosome 12 and another gained 
chromosome 22. No evidence for increased rates of trisomy 21 in the assessed AD samples 
was found (tables 1 and S3). The total neuronal aneuploidy rates in AD were comparably low 
as in control samples (0.6% 95%CI: 0.2%-1.3%, n=893). Again, these aneuploidy rates are 
significantly lower than reported previously (Mann-Whitney-Wilcoxon rank test, p<0.001 for 
chr. 1, 7, 11, 14, 17, 18 21 and X in Iourov et al. 12, and for chr1, 7, 11, 16, 17, 18 and X in Yurov 
et al.14). Importantly, we can exclude detection issues, as we observed trisomy 21 in all 
neurons sampled from a DS control individual. Furthermore, we failed to detect selective gains 
of the other recurring AD chromosome gains reported in AD (e.g. trisomy 11 and 17). In fact, 
the few aneuploidies we did detect appeared to be random, as no particular chromosome loss 
or gain was found in more than 2 cells.  
Interestingly, a recent study using single-cell qPCR reported the presence of local copy number 
gains, up to 12 copies, of the APP locus in AD neurons 20. Even though the goal of our scWGS 
study was to examine whole chromosome copy number variation, we investigated this region 
more closely in AD neurons. No copy number gains of the APP locus were observed (Fig S4).  
Although we do not observe a selective gain of chromosome 21 in neurons from AD patients, 
there is still a very compelling observation that individuals with DS develop early onset 
dementia with brain lesions similar as observed in AD patients 16. As we focused our 
sequencing efforts on neurons only, we cannot rule out the possibility that aneuploidy in other 
cell lineages in the brain is involved in the pathogenesis of AD. Increasing evidence suggests 
an important contribution of the immune system to AD pathogenesis (reviewed in 21,22). Both 
microglia and astrocytes, the CNS-resident innate immune cells, have been shown to be 
involved in the onset and progression of AD. So far, no single cell sequencing data is available 
of these types of cells from AD brains. Therefore, we also analyzed some non-neuronal (NeuN-
negative) nuclei from a control (n=63) and an AD (n=51) sample by scWGS. We found no 
aneuploid cells in either of these non-neuronal controls (Fig. 4 and table S3). However, no 
clear distinction was made between the non-neuronal cells and further studies are needed to 
exclude a potential role of aneuploidy in cell types such as microglia or astrocytes in AD 
neurodegeneration. Taken together, our analysis using scWGS reveals that the prevalence of 
aneuploid cells in the frontal cortex of control individuals and AD patients is very low.  
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clear distinction was made between the non-neuronal cells and further studies are needed to 
exclude a potential role of aneuploidy in cell types such as microglia or astrocytes in AD 
neurodegeneration. Taken together, our analysis using scWGS reveals that the prevalence of 
aneuploid cells in the frontal cortex of control individuals and AD patients is very low.  





Figure 4. scWGS reveals no common aneuploidy in AD non-neuronal cells. Whole genome copy 
number profiles from non-neuronal cells from control 5 (female, n=63) (A), and AD 10 (female, n=51) 
(B). Each row represents a single cell with chromosomes plotted as columns. Cells are clustered based 
on the similarity of their copy number profile. Copy number states are depicted in different colors (see 




Many recent studies have reported a high prevalence of aneuploid neurons in AD brains, 
which led to the hypothesis that neuronal aneuploidy could be involved in the pathogenesis 
of AD. However, using a single cell sequencing approach, we report low levels of aneuploidy 
both in neurons from AD patients as well as in neurons from non-diseased individuals. The 
level of neuronal aneuploidy in our study is much lower than was previously reported 1,5,11–15. 
Nevertheless several lines of evidence strongly support our results. First, our method clearly 
detected trisomy of chromosome 21 in a DS sample and monosomy of chromosome X in all 
male samples showing the accuracy of our approach. Importantly, the validity of our scWGS 
method to study CNVs in leukemic and solid tumor samples was validated with array CGH in 
separate studies (Bakker et al. on page X of this issue and Paranita et al., personal 
communication). The study by Bakker et al., also provides evidence that our technique can 
detect complex and partial aneuploidies. Second, the aneuploidy rates that we find in normal 
healthy neurons are more in line with recent findings from other single cell sequencing studies 
6–8. Third, we analyzed over 1500 neuronal nuclei, which is to our knowledge the largest single 
cell sequencing dataset so far. Therefore, although more AD-affected brains should be 
assessed to exclude rare cases, our results do not support an important role for neuronal 







Materials and Methods 
Tissue sources 
Fresh-frozen postmortem brain samples from the frontal cortex were obtained from the Dutch 
Brain Bank and from the department of Pathology & Medical Biology of the University Medical 
Center Groningen (UMCG). In this study samples from 6 non-demented controls (Braak stage 
0-I) and 10 AD patients (Braak stage III-VI) were used. Patient details are listed in Table 1. A 
fresh-frozen postmortem brain sample from an individual with Down’s syndrome served as a 
positive control for the detection of trisomy of chromosome 21.  
 
Amyloid plaque staining 
Amyloid staining was performed to confirm the presence of amyloid plaques in the brain 
samples with Braak stage III and VI. Immunohistochemical staining with antibodies directed at 
Aβ (4G8, 1:500, Biolegend, 800702) was done on 10 µm frozen brain sections. The sections 
were pre-incubated in 0.3% H2O2 for 30min and blocked with 10% normal horse serum in PBS 
with 0.3% Triton-X100 (Sigma, 9002-93-1) for 30 min. Hereafter, sections were incubated 
overnight at 4°C with the Aβ primary antibody in PBS containing 0.3% Triton-X100 and 1% 
normal goat serum. Unbound antibodies were washed away with PBS and sections were 
incubated for 1 hour at room temperature with horse anti-mouse biotinylated secondary 
antibody (1:400, Vector, BA-2000). Finally, the sections were incubated in avidin-biotin-
peroxidase complex (Vectastain ABC kit, Vector Laboratories, PK-6100) for 30 min and 
visualized with diaminobenzidine (Sigma, D-5637). Counterstaining was performed with cresyl 
violet for 2 min. 
 
Isolation of neuronal and non-neuronal nuclei  
From each sample 10 sections of 50µm or a small tissue block (~0.5-1 cm2), cut into pieces, 
was used for nuclei isolation. Neuronal nuclei isolation was performed as described previously 
18 with minor modifications. Samples were kept on ice throughout the nuclei isolation 
procedure. In short, tissue sections were incubated in nuclear isolation buffer (10mM Tris-HCl 
(pH 8), 320mM sucrose, 5mM CaCl2, 3mM Mg(Ac)2, 0.1mM EDTA, 1mM dithiothreitol (DTT) 
and 0.1% Triton X-100) for 5 minutes and filtered through a 70µm filter using a plunger. 
Hereafter, nuclei were purified by ultracentrifugation (107,000g for 2.5 hours at 4°C) through 
a dense sucrose buffer (10mM Tris-HCl (pH 8), 1.8M sucrose, 3mM Mg(Ac)2, 0.1mM EDTA and 
1mM DTT). Supernatant was removed from the pelleted nuclei that were washed and 
resuspended in PBS containing 2% bovine serum albumin (BSA) (PBS/2%BSA). Isolated nuclei 
were stored in nuclei storage buffer (50mM Tris-HCl (pH 8), 5mM Mg(Ac)2, 0.1mM EDTA, 5mM 
DTT and 40% glycerol) at -80°C. On the day of sorting, nuclei were washed with PBS/2%BSA 
and resuspended in PBS/2%BSA containing an antibody directed against the nuclear neuronal 
marker NeuN (1:100.000, Millipore) and 4',6-diamidino-2-phenylindole (DAPI; 10 µg/ml) and 
incubated for 45-60 minutes on ice. Single NeuN-positive or NeuN-negative and DAPI low 
nuclei were sorted into 5µl freezing buffer (50% PBS, 7.5% DMSO and 42.5% 2X ProFreeze-
CDM (Lonza)) in individual wells of a 96 well plate using MoFlo-Astrios (Beckman Coulter). 
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Ninety-two single nuclei were sorted per plate. In two wells of each plate 10 nuclei were sorted 
as positive control and two wells without nuclei served as negative control. Plates were 
subsequently centrifuged at 500g for 5 minutes at 4°C before being gradually frozen to -80°C 
in styrofoam boxes. Plates were stored at -80°C until library preparation.  
 
Pre-amplification-free scWGS library preparation 
Pre-amplification-free scWGS library preparation was performed using a modified version of 
a protocol described before 23. All pipetting steps are performed using a Bravo Automated 
Liquid Handling Platform (Agilent technologies, Santa Clara, USA). All DNA purification steps 
between enzymatic reactions were performed using AMPure XP magnetic beads (Agencourt 
AMPure, Beckman Coulter, Brea, California, USA). All enzymes used in the library preparation 
are obtained from New England Biolabs. After DNA fragmentation by micrococcal nuclease, 
End repair and A-tailing of the DNA fragments was performed in one reaction mix including T4 
DNA polymerase, T4 polynucleotide kinase and Bst 2.0 warm start polymerase. End repair was 
performed at 25°C for 30 minutes followed by the A-tailing reaction at 68°C for 30 minutes. 
Subsequently without DNA purification, ligation reaction mixture containing T4 DNA ligase 
was added and Illumina PE forked adapters were ligated to either side of the DNA fragments. 
After clean up, the adapter containing DNA fragments were directly subjected to 17 cycles of 
PCR using Phusion High Fidelity DNA polymerase and custom barcoded primers. After PCR 




Since each single cell library received a unique barcode, libraries can be pooled (multiplexed) 
and sequenced together. Per 96 wells plate, the full volume (6µl) of the single nuclei and 
negative controls were pooled together with 1 µl of the 10 nuclei controls. Size selection was 
performed on a 2% E-gel EX (Invitrogen) to isolate the mononucleosome fragments of 
approximately 280 bp (range of 200-400 bp). The DNA was eluted from the gel slices using 
Zymoclean gel DNA recovery kit (Zymo) according to manufacturer’s protocol. The DNA 
quantity and quality were assessed using Qubit fluorometer (Invitrogen) and Bioanalyzer with 
High sensitivity chips (Agilent) respectively. For sequencing, clusters were generated on the 
cBot and single-end 50nt reads were generated using the HiSeq2500 sequencing platform 




After demultiplexing, all reads were aligned to the human reference genome (GRCh37) using 
short read aligner Bowtie2 (version 2.2.4) 24 with default settings. The resulting BAM files were 
sorted using Samtools (version 0.1.18) 25 and duplicate reads were marked using BamUtil 
(version 1.0.3). Duplicate reads and ambiguous alignments (MAPQ>10) were filtered out using 
Aneufinder. Estimated complexity was calculated by down sampling the reads several times 
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and determining the fraction of unique reads each time. Then the number of reads sequenced 
(seq_reads) was plotted against the number of unique reads (uni_reads) and a curve was fitted 
through the data points using the formula: 
uni_reads = (Cmax*seq_reads)/(K+seq_reads), 
where Cmax was used as an estimation of the complexity of the library: the theoretical 
maximum unique reads in that library. K is the number of sequenced reads at which the 
number of unique reads is half of the library complexity. For subsequent CNV assessment, a 
custom pipeline was developed called AneuFinder (Bakker et al. on page X of this issue; add 
reference for this paper later). Briefly, uniquely mapped reads are counted in, non-
overlapping bins of variable size based on mappability with a mean of 1 Mb in size (for details: 
see Bakker et al.). GC corrected uniquely mapped read counts, were used as observables in a 
Hidden Markov Model (HMM) with several possible hidden copy number states from 
nullisomy up to decasomy (10 copies). The emission distributions were modeled with a delta 
distribution for the nullsomy state and with negative binomial distributions for all other states, 
with means and variances that were fixed to multiples of the monosomy-state ones. 
Parameter estimates were obtained using the Baum-Welch algorithm. The final CNV calls were 
determined as the state with the highest posterior probability for each bin.  
 
Quality control 
The quality of each library was assessed with several criteria: genomic coverage, bin-to-bin 
variation in read density (spikiness), entropy, number of ploidy state segments and 
Bhattacharyya distance. Using the AneuFinder function “ClusterByQuality”, the libraries were 
clustered based on similarity of the quality control aspects (described in detail in Bakker et al. 
on page X of this issue; add reference for this paper later). From each sample the highest 
quality cluster, each of which had spikiness < 0.21, and Bhattacharyya distance > 1.0, were 
considered good quality libraries and used for aneuploidy calling.  
 
Statistics 
Wilcoxon rank sum test was used to compare groups using wilcox.test in R. P values < 0.05 
were considered significant.   
 
Ethics 
All subjects who donated tissue to the Dutch Brain bank have given written informed consent. 
The remaining tissue samples were treated in accordance with the national guideline “Code 
Goed Gebruik van Patienten Materiaal” (Code of Good Use of Patient Material). All 
experimental methods comply with the Helsinki Declaration.  
 
Availability of supporting data 
The data set(s) supporting the results of this article are available in the ArrayExpress 
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Figure S1. Single cell, pre-amplification-free library preparation protocol overview. Schematic 
representation of the library preparation protocol used: after sorting in 96 wells plates, the DNA is 
fragmented using MNase. End repair and A-tailing are combined in one reaction and directly followed 
with ligation of the adapters. Barcodes are introduced during the PCR, and after pooling and size 
















Figure S2. scWGS reveals no common aneuploidy in controls. Genome wide copy number profiles 
from single cell libraries of 5 control individuals. Each row represents a single cell with chromosomes 
plotted as columns. Cells are clustered based on the similarity of their copy number profile. Copy 
number states are depicted in different colors.  
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Figure S2. scWGS reveals no common aneuploidy in controls. Genome wide copy number profiles 
from single cell libraries of 5 control individuals. Each row represents a single cell with chromosomes 
plotted as columns. Cells are clustered based on the similarity of their copy number profile. Copy 
number states are depicted in different colors.  




Figure S3. scWGS reveals no common aneuploidy in AD. Genome wide copy number profiles from 
single cell libraries of 8 AD patients. Each row represents a single cell with chromosomes plotted as 
columns. Cells are clustered based on the similarity of their copy number profile. Copy number states 





Figure S3. (continued) 
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Figure S3. scWGS reveals no common aneuploidy in AD. Genome wide copy number profiles from 
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Figure S4. No local copy number variations at APP locus in AD neurons. UCSC genome browser view 








Figure S4. No local copy number variations at APP locus in AD neurons. UCSC genome browser view 
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